Jul. 2 at 7:33 PM
$IBRX anyone who says the
$RUT recon where ibrx stayed put in r2000 doesn't matter is uninformed and not that bright,.
Due to it's sp gain since Jan it was awarded a much higher weight in index thus increasing the support it gets in funds like xbi,
$IBB ,vanguard...
ibrx is poised for significant momentum as the broader biotech sector rallies. With Investors capitalizing on both the technical breakout in the SPDR S&P Biotech XBI, yes breakoutlike i been sayin, and institutional rebalancing stand to benefit from a powerful tailwind.
XBI is on breakout watch.
Technical Setup: Breaking above the
$160.07 resistance with clear air above opens up immediate upside Target at
$169.19(+6.6% from
$160.
Sector Impact: As XBI leads and supports the broader biotech space, high-beta constituents like ImmunityBio, Inc. are highly likely to track or exceed the ETF's performance.
Now imagine if you will that due to it's near overbought zone, that a simple pr is released and ibrx has a breakout on it's own!
